Phreesia, Inc. (PHR)
| Market Cap | 1.47B |
| Revenue (ttm) | 405.14M |
| Net Income (ttm) | -82.78M |
| Shares Out | 58.12M |
| EPS (ttm) | -1.45 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 102,497 |
| Open | 25.12 |
| Previous Close | 25.16 |
| Day's Range | 24.88 - 25.64 |
| 52-Week Range | 17.07 - 29.16 |
| Beta | 0.99 |
| Analysts | Strong Buy |
| Price Target | 29.38 (+16.5%) |
| Earnings Date | Dec 9, 2024 |
About PHR
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to d... [Read more]
Financial Performance
In 2023, Phreesia's revenue was $356.30 million, an increase of 26.84% compared to the previous year's $280.91 million. Losses were -$136.89 million, -22.29% less than in 2022.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for PHR stock is "Strong Buy." The 12-month stock price forecast is $29.38, which is an increase of 16.50% from the latest price.
News
Phreesia Has Turned The Corner, Can It Continue To Mend?
Phreesia's Q3 earnings show solid revenue growth, but customer growth is decelerating, impacting overall performance. Fiscal 2025 guidance improved with higher EBITDA and tighter revenue estimates, wh...
Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript
Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript
Phreesia Announces Third Quarter Fiscal 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "W...
Phreesia Named to The Software Report's “Top 100 Software Companies” for the Third Consecutive Year
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year.
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024.
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform...
Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has joined the NAI to shape the national conversation around data privacy and promote consumer choice and transparency.
Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns
ALL-REMOTE COMPANY/WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia has collaborated with the Ad Council to bring three public health campaigns about mental health directly to patients and careg...
Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that its contract with the CMS Innovation Center for use of the Patient Activation Measure® has been renewed to 20...
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence
ALL-REMOTE COMPANY/WILMINGTON, Del. & LAFAYETTE, Colo. & SAN FRANCISCO--(BUSINESS WIRE)--The CDC awards grant to Phreesia, NAFC, Health.Equity.Outcomes. and Christina Escobar, MD, at NYU, to combat ur...
Phreesia: Remain Bullish Given The Healthy Growth Outlook
I maintain a buy rating for PHR, driven by strong client growth, solid revenue outlook, and increasing transaction sizes in the pipeline. PHR's 2Q25 results show 19% y/y revenue growth and improved pr...
Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript
Phreesia, Inc. (NYSE:PHR) Q2 2025 Earnings Conference Call September 4, 2024 5:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference C...
Phreesia Announces Second Quarter Fiscal 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2024. "We ...
Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination
ALL-REMOTE COMPANY/WILMINGTON, Del. & ITASCA, Ill.--(BUSINESS WIRE)--Phreesia announces that it has teamed up with the American Academy of Pediatrics to help increase measles, mumps and rubella immuni...
Bob Glazer Joins Phreesia as Strategic Advisor
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that it has named Bob Glazer as the company's Strategic Advisor.
Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal second quarter 2025 financial results after the close of market trading on Sept. 4, 2024.
Phreesia Now Available on Oracle Healthcare Marketplace
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is now available on the Oracle Healthcare Marketplace and can be integrated with the Oracle Health Electronic Health Record (EHR).
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK, NY / ACCESSWIRE / June 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Inv...
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia partners with the National Kidney Foundation and shares new research on early diagnosis and treatment of kidney disease.
Phreesia: Growth Remains Strong, With EBITDA Margin Set To Improve
Phreesia's revenue grew 20.7% year-over-year, with subscription revenue growing 23.4% and payment processing revenue growing 11.6%. The company added 103 new clients in the quarter, beating guidance, ...
Phreesia, Inc. (PHR) Q1 2025 Earnings Call Transcript
Phreesia, Inc. (NYSE:PHR) Q1 2025 Results Conference Call May 30, 2024 5:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Pa...
Phreesia Announces First Quarter Fiscal 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2024. "I a...
Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has joined the MEDITECH Alliance Program as an Innovator Partner.
Phreesia's Amy Patel Named One of PM360's 2024 ELITE 100
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that PM360 has named Amy Patel, MPH, Director of Analytics, as one of its 2024 PM360 ELITE 100.